Future Tech
U.S. judge rules Apple Watches infringed Masimo patent - medical device maker
A U.S. judge ruled that Apple had infringed on one of Masimo Corp's pulse oximeter patents by importing and selling certain Apple Watches with light-based pulse oximetry functionality and components, Masimo said on Tuesday.
The United States International Trade Commission (USITC) will now consider whether to implement an import ban on these Apple Watches, the medical device maker said.
- Reuters
More articles on Future Tech
Elon Musk revives lawsuit against Sam Altman and OpenAI, filing shows
Created by Tan KW | Aug 05, 2024
Nvidia reportedly delays Blackwell GPUs until 2025 over packaging issues
Created by Tan KW | Aug 05, 2024
AI chip startup Groq valued at $2.8 billion after latest funding round
Created by Tan KW | Aug 05, 2024
Magnificent Seven set to shed $1 trillion in value, led by Apple, Nvidia
Created by Tan KW | Aug 05, 2024
Elon Musk revives lawsuit against Sam Altman and OpenAI, filing shows
Created by Tan KW | Aug 05, 2024
CrowdStrike unhappy about Delta's 'litigation threat,' claims airline refused 'free on-site help'
Created by Tan KW | Aug 05, 2024
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
Apps
Top Articles
1
THE INVESTMENT APPROACH OF CALVIN TAN
3
https://dividendguy67.blogspot.com
4
Good Articles to Share
China stocks buck global sell-off as services activity rises; Hong Kong slips
5
6
Good Articles to Share
7
8
Genetec - A baby step
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
MQ Trading Signals
Stock
Time
Signal
Duration
Stock
Time
Signal
Duration
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
